Lisper Wangeci Njeri
Biographic Data
| ID | 10001067 |
|---|---|
| NAME | Lisper Wangeci Njeri |
| GIVEN NAMES | Lisper Wangeci |
| FAMILY NAME | Njeri |
| SIGNATURE | NJERI L W |
| AFFILIATIONS | Kenyatta National Hospital |
| ORCID | 0000-0002-1559-2788 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future
Background: Diabetes mellitus rates continue to rise, which coupled with increasing costs of associated complications has appreciably increased global expenditure in recent years. The risk of complications are enhanced by poor glycaemic control including hypoglycaemia. Long-acting insulin analogues were developed to reduce hypoglycaemia and improve adherence. Their considerably higher costs though have impacted their funding and use. Biosimilars …
No prominent works on this page.
The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future
Background: Diabetes mellitus rates continue to rise, which coupled with increasing costs of associated complications has appreciably increased global expenditure in recent years. The risk of complications are enhanced by poor glycaemic control including hypoglycaemia. Long-acting insulin analogues were developed to reduce hypoglycaemia and improve adherence. Their considerably higher costs though have impacted their funding and use. Biosimilars …
Biosimilar (1 works) · Biosimilars and Bioanalytical Methods (1 works) · Business (1 works) · Endocrinology (1 works) · Environmental health (1 works) · Hypoglycemia (1 works) · Insulin (1 works) · Insulin glargine (1 works) · Internal Medicine (1 works) · Medicine (1 works)